Fraunhofer Institute for Cell Therapy and Immunology IZI

New Managing Director at Fraunhofer IZI

Press release | January 16, 2018

more info

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering.

One of the institute's main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharmaceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products for the business units Cell and Gene Therapy, Drugs, Diagnostics and Biosystems Technology.

Its areas of competence lie in cell biology, immunology, drug biochemistry, biomarker, bioanalytics and bioproduction as well as process development and automation.

In these areas, research specifically focusses on the indications oncology, neuropathology, autoimmune and inflammatory diseases as well as infectious diseases and regenerative medicine.

The institute works in close cooperation with hospital institutions and performs quality tests besides carrying out the GMP-compliant manufacture of clinical test samples. Furthermore, it helps partners obtain manufacturing licenses and permits.

Business units

Jobs / career





Press information / 16.1.2018

New Managing Director at Fraunhofer IZI

Prof. Dr. Dr. Ulrike Köhl is the new managing director at the Fraunhofer Institute for Cell Therapy and Immunology (IZI). As the newly appointed professor of immuno-oncology at Leipzig University, Prof. Köhl has also managed the Institute of Clinical Immunology at Leipzig University Hospital since mid-December. Previously, as a scientist specialising in cellular immunotherapies, she worked as a professor at the Hannover Medical School.

Press information / 4.12.2017

Sage and bitter apple: plant extracts as active agents for the treatment of chronic inflammatory bowel diseases

Researchers at Fraunhofer IZI demonstrate that plant extracts taken from sage and bitter apple have the potential to be used as active agents against chronic inflammatory bowel diseases.

Press information / 4.12.2017

Chronic Colitis: New Model for Translational Research

Researchers at Fraunhofer IZI present a new, more expressive model for the preclinical investigation of chronic inflammatory bowel diseases.


Press information / 10.11.2017

Fraunhofer Life Science Symposium: Latest Developments in the Field of Infection Diagnostics

The Fraunhofer Life Science Symposium will be held in Leipzig from 8 – 9 November 2017. The event will see around 180 participants discussing the latest developments in the diagnosis of infectious diseases. The symposium is organized by the Fraunhofer Institute for Cell Therapy and Immunology IZI.


Fraunhofer IZI


Perlickstraße 1
04103 Leipzig

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000



Social Media